The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model
article
OA: closed
CC0
⤵ 15 in-corpus citations
AI-generated summary
Infliximab, etanercept, and letrozole treatments in a rat endometriosis model reduced implant size while increasing plasma ADMA and decreasing plasma nitrate/nitrite levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AIM: To investigate the levels of nitric oxide (NO) and asymmetric dimethylarginine (ADMA) in all the rat endometriosis models. MATERIAL & METHODS: Forty-one rats with endometriotic implants were divided into four groups (1 to 4) and administered infliximab, etanercept, letrozole and control, respectively. There were 11 rats in group 5 (normal). The size of implants, plasma ADMA and nitrate/nitrite (NO(x) ) levels and histological score were assessed. RESULTS: In groups 1, 2 and 3, plasma ADMA levels were higher than groups 4 and 5, 296.8 ± 66.2, 285.9 ± 35.7, 200.3 ± 41.0, 125.3 ± 16.7, 111.3 ± 6.5 µmol/L, respectively, while NO(x) levels were lower than groups of control and normal 19.6 ± 3.8, 19.8 ± 4.4, 39.3 ± 6.1, 80.5 ± 5.3, and 91.1 ± 5.0 µmol/L, respectively. CONCLUSIONS: Infliximab, etanercept and letrozole have regressed endometriotic implants, decreased plasma NO(x) levels, and increased plasma ADMA levels.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- Angiogenic Factors in Endometriosis via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
- Cell proliferation is increased in the endometrium of women with endometriosis via openalex
- Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis via openalex
- Interleukin‐1 Stimulates Macrophage Migration Inhibitory Factor Secretion in Ectopic Endometrial Cells of Women with Endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Pathological evaluation of the rat endometriosis model via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Serum and endometrial markers via openalex
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis via openalex
- W2060449870 via openalex
- W2060546762 via openalex
- W2073950591 via openalex
- W2079911821 via openalex
- W2092859490 via openalex
- W2106478344 via openalex
- W2112487069 via openalex
- W2142943611 via openalex
- W2151554519 via openalex
- W2166969544 via openalex
- W2284473629 via openalex
- W2328664855 via openalex
- W4211081176 via openalex
- W1971061508 via openalex
- W1971586374 via openalex
- W1971746374 via openalex
- W1973123086 via openalex
- W1998523124 via openalex
- W2000881220 via openalex
- W2007361075 via openalex
- W2009029293 via openalex
- W2032519662 via openalex
- W2032562223 via openalex
- W2050593194 via openalex
- W2058385357 via openalex
- W2058521337 via openalex
Cited by (15)
- What We Have Learned from Animal Models to Understand the Etiology and Pathology of Endometrioma-Related Infertility 2022
- Medical treatments of endometriosis: a review 2022
- Immunosuppression and immunotherapy in endometriosis 2021
- Pain 2021
- Endometriosis Classification and The Role of Tumor Necrosis Factor-Alpha Polymorphisms as A Therapeutic Target. 2020
- INFLUENCE OF CYTOKINES PRODUCTION, NITROGEN OXIDE METABOLITES AND LIPIDS EXCHANGE ON THE FORMATION OF EXTERNAL GENITAL ENDOMETRIOSIS STAGES IN PATIENTS OF REPRODUCTIVE AGE 2020
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Current and emerging treatment options for endometriosis 2018
- Medical Management of Endometriosis 2017
- An Update on Pathophysiology and Medical Management of Endometriosis 2016
- The effects of lauromacrogol injection into rat endometrial cysts: a preliminary experimental study 2016
- An overview of early drug development for endometriosis 2015
- A tumor necrosis factor-α inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid 2013
- New approaches to the treatment of endometriosis 2013
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0
· commercial use OK